Skip to content
Screener

Johnson & Johnson JNJ Q2 2026 earnings

Reported July 15, 2026 · Before market open

Revenue$25.3BBeat by $247.7M
EPS$2.90Beat by $0.06
Revenue estimate$25.1B
EPS estimate$2.84
“Johnson & Johnson delivered strong second-quarter results, demonstrating the power of our innovation, the depth of our portfolio and the momentum in our pipeline as we advance transformative treatments that address the world's toughest health challenges”
Joaquin Duato

Next report

Oct 13, 2026 (In 1 week)
Revenue estimate$25.4B
EPS estimate$2.78

Financials

Q2 2026

Income statement

See full
Revenue$25.3B+6.6%
Gross profit$17.3B+7.1%
Operating income$7.1B+7.4%
Net income$5.5B-0.1%
EPS (diluted)$2.27-0.9%

Balance sheet

See full
Cash & equivalents$20.4B+9.9%
Total debt$49.0B-3.4%
Total equity$85.0B+8.3%
Total assets$201.06B+4.0%

Cash flow

See full
Operating cash flow$8.6B+122%
CapEx$1.3B+26.7%
Free cash flow$7.3B+157%

Valuation & ratios

Valuation

as of 10/02/26
See full
Market cap$623.34B+39.2%
Enterprise value$651.96B+37.1%
P/E29.6×+11.8×
P/S6.4×+1.5×

Profitability

See full
Gross margin67.9%0.0pp
Operating margin26.5%+2.8pp
Net margin21.5%-3.5pp
FCF margin22.7%+2.2pp

Returns & leverage

See full
Return on equity25.7%-4.5pp
Debt / equity0.6×-0.1×
Current ratio1.1×+0.1×

Segments

By product

See full
DARZALEX$4.2B+18.9%
Other$2.8B-1.8%
Tremfya$2.0B+72.5%
GENERAL$1.5B+5.2%
ADVANCED$1.2B+2.1%

By geography

See full
Europe$5.7B+6.3%
Asia-Pacific, Africa$3.7B+3.8%
Western Hemisphere, excluding U.S.$1.3B+8.5%

By segment

See full
Innovative Medicine$16.4B+7.8%
MEDTECH$8.9B+4.5%

FAQ

When did Johnson & Johnson report Q2 2026 earnings?
Johnson & Johnson (JNJ) reported Q2 2026 earnings on July 15, 2026 before market open.
What were Johnson & Johnson's Q2 2026 revenue and EPS?
Johnson & Johnson reported revenue of $25.3B and eps of $2.90 for Q2 2026.
Did Johnson & Johnson beat estimates in Q2 2026?
Revenue beat the consensus estimate of $25.1B by $247.7M. EPS beat the consensus estimate of $2.84 by $0.06.
How did Johnson & Johnson's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 6.6% from $23.7B a year earlier and eps grew 4.7% from $2.77.
Where can I find Johnson & Johnson's Q2 2026 SEC filings?
You can read the 8-K earnings release (0000200406-26-000146) and the 10-Q periodic report (0000200406-26-000153) directly on SEC EDGAR. The filing index links above go to sec.gov.